Lactoferrin ( Bovine or Human ) Identified as a potential COVID candidate
We found lactoferrin had remarkable efficacy for preventing infection (in a Lab setting) , working better than anything else we observed,” Sexton said. He adds that early data suggest this efficacy extends even to newer variants of SARS-CoV2, including the highly transmissible Delta variant.
#lactoferrin #bovine #compound
Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19
Carmen Mirabelli, Jesse W. Wotring, Charles J. Zhang, Sean M. McCarty, Reid Fursmidt, Carla D. Pretto, Yuanyuan Qiao, Yuping Zhang, Tristan Frum, Namrata S. Kadambi, Anya T. Amin, Teresa R. O’Meara, Jason R. Spence, Jessie Huang, Konstantinos D. Alysandratos, Darrell N. Kotton, Samuel K. Handelman, Christiane E. Wobus, Kevin J. Weatherwax, George A. Mashour, Matthew J. O’Meara, Arul M. Chinnaiyan, Jonathan Z. Sexton
Proceedings of the National Academy of Sciences Sep 2021, 118 (36) e2105815118; DOI: 10.1073/pnas.2105815118
Lactoferrin, bovine, prophylaxis, cytokine storm, SARS-CoV-2, therapeutic intervention, TNF, IL-6, interferon-stimulated genes, infection, multimodal, repurposing, betacoronavirus, iAEC2